Literature DB >> 27832356

Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases.

Jian-Xia Jiang1, Qing Liu2, Bing Zhao3, Hai-Han Zhang1, Huai-Ming Sang1, Soyfoo-Muhammad Djaleel1, Guo-Xin Zhang1, Shun-Fu Xu4.   

Abstract

PURPOSE: To identify risk factors for intestinal metaplasia in a southeastern Chinese population.
METHODS: Subjects who underwent upper GI endoscopy and endoscopic biopsy in the First Affiliated Hospital of Nanjing Medical University from 2008 to 2013 were included into this study. Various demographic, geographic, clinical and pathological data were analyzed separately to identify risk factors for intestinal metaplasia.
RESULTS: The incidence of intestinal metaplasia differed significantly in 17 municipal areas ranging from 16.79 to 38.56% and was positively correlated with the age range of 40-70 years, male gender, gastric ulcer, bile reflux, Helicobacter pylori infection, atrophic gastritis, dysplasia, gastric cancer, degree of chronic and acute inflammation, and gross domestic product per capita (P < 0.01). Multivariate linear regression analysis indicated that only gross domestic product per capita revealed a significant difference in the incidence of intestinal metaplasia among all factors mentioned.
CONCLUSION: This study confirms age, male gender, gastric ulcer, bile reflux, H. pylori infection, severe degree of chronic and acute inflammation to be the risk factors for intestinal metaplasia. We speculate that the gross domestic product per capita of different areas may be a potential independent risk factor impacting the incidence of intestinal metaplasia.

Entities:  

Keywords:  Gross domestic product per capita; Helicobacter pylori infection; Inflammation; Intestinal metaplasia; Risk factors

Mesh:

Year:  2016        PMID: 27832356     DOI: 10.1007/s00432-016-2299-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  A national study of Helicobactor pylori infection in gastric biopsy specimens.

Authors:  Amnon Sonnenberg; Richard H Lash; Robert M Genta
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

2.  Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain.

Authors:  Carlos A González; Maria Luisa Pardo; Juan Maria Ruiz Liso; Pablo Alonso; Catalina Bonet; Raul M Garcia; Núria Sala; Gabriel Capella; José Miguel Sanz-Anquela
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

3.  Geographic pathology of Helicobacter pylori gastritis.

Authors:  Yi Liu; Cyriel I J Ponsioen; Shu-Dong Xiao; Guido N J Tytgat; Fiebo J W Ten Kate
Journal:  Helicobacter       Date:  2005-04       Impact factor: 5.753

4.  The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer.

Authors:  C M den Hoed; B C van Eijck; L G Capelle; H van Dekken; K Biermann; P D Siersema; E J Kuipers
Journal:  Eur J Cancer       Date:  2011-01-14       Impact factor: 9.162

Review 5.  Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.

Authors:  E J Kuipers
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

6.  Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer.

Authors:  W K Leung; J J Kim; J G Kim; D Y Graham; A R Sepulveda
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

8.  A model for gastric cancer epidemiology.

Authors:  P Correa; W Haenszel; C Cuello; S Tannenbaum; M Archer
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

9.  Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia.

Authors:  Christian Felley; Hanifa Bouzourene; Marianne Bründler G VanMelle; Antoine Hadengue; Pierre Michetti; Gian Dorta; Laurent Spahr; Emiliano Giostra; Jean Louis Frossard
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  12 in total

1.  Predictability of gastric intestinal metaplasia by patchy lavender color seen on linked color imaging endoscopy.

Authors:  Honglei Chen; Huashe Wang; Xiaobin Wu; Yanan Liu; Qiuning Wu; Yi Lu; Xutao Lin; Dejun Fan; Chujun Li
Journal:  Lasers Med Sci       Date:  2019-03-22       Impact factor: 3.161

2.  HDAC6/FOXP3/HNF4α axis promotes bile acids induced gastric intestinal metaplasia.

Authors:  Luyao Zhang; Na Wang; Min Chen; Siran Wu; Jiaoxia Zeng; Fenli Zhou; Qiong Wu; Junye Liu; Yongquan Shi
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  Ability of blue laser imaging with magnifying endoscopy for the diagnosis of gastric intestinal metaplasia.

Authors:  Honglei Chen; Yanan Liu; Yi Lu; Xutao Lin; Qiuning Wu; Jiacheng Sun; Chujun Li
Journal:  Lasers Med Sci       Date:  2018-05-18       Impact factor: 3.161

4.  hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathway.

Authors:  Bai-Jun Chen; Shuo Zeng; Rui Xie; Chang-Jiang Hu; Su-Ming Wang; Yu-Yun Wu; Yu-Feng Xiao; Shi-Ming Yang
Journal:  Oncotarget       Date:  2017-04-18

5.  AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.

Authors:  Osama Altayar; Perica Davitkov; Shailja C Shah; Andrew J Gawron; Douglas R Morgan; Kevin Turner; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

6.  MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.

Authors:  Ting Li; Hanqing Guo; Hong Li; Yanzhi Jiang; Kun Zhuang; Chao Lei; Jian Wu; Haining Zhou; Ruixue Zhu; Xiaodi Zhao; Yuanyuan Lu; Chongkai Shi; Yongzhan Nie; Kaichun Wu; Zuyi Yuan; Dai-Ming Fan; Yongquan Shi
Journal:  Gut       Date:  2019-01-11       Impact factor: 23.059

7.  HDAC6/HNF4α loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia.

Authors:  Na Wang; Min Chen; Zhen Ni; Ting Li; Jiaoxia Zeng; Guofang Lu; Jiaojiao Wang; Jian Zhang; Siran Wu; Yongquan Shi
Journal:  Gastric Cancer       Date:  2020-07-23       Impact factor: 7.370

8.  Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China.

Authors:  Xujuan Liu; Min Zhang; Riyu Luo; Keran Mo; Xingxiang He
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

9.  Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach.

Authors:  Na Wang; Siran Wu; Jing Zhao; Min Chen; Jiaoxia Zeng; Guofang Lu; Jiaojiao Wang; Jian Zhang; Junye Liu; Yongquan Shi
Journal:  Cell Oncol (Dordr)       Date:  2021-09-12       Impact factor: 6.730

Review 10.  Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.

Authors:  Shailja C Shah; Andrew Canakis; Richard M Peek; Monica Saumoy
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-21       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.